Moreover, the recent divergence, thus high level of sequence similarity, of human Aurora-B and Aurora-C suggests a novel anti-cancer strategy which might simultaneously target the ATP-binding domains of this kinase pair with dual action inhibitors. Here, AURKC is linked to cancer.